Key result
Increased epicardial adipose tissue thickness in patients with stable IHD and borderline coronary stenosis was associated with higher levels of miR-208 (p=0.001) and increased NTproBNP (p=0.002).
Why the study?
The study was conducted to evaluate microRNA levels and epicardial adipose tissue thickness in patients with ischemic heart disease and borderline coronary artery stenosis.
Is increased epicardial adipose tissue thickness associated with altered microRNA and NTproBNP levels in patients with stable ischemic heart disease and borderline coronary artery stenosis?
Observational (n=201)
Is increased epicardial adipose tissue thickness associated with altered microRNA and NTproBNP levels in patients with stable ischemic heart disease and borderline coronary artery stenosis?
Answers are grounded in this paper and cite their sources.
Increased epicardial adipose tissue thickness in patients with stable ischemic heart disease and borderline coronary stenosis is associated with elevated miR-208 and NTproBNP, suggesting active cardiac remodeling and potentially poorer prognosis.
Objective: To assess the levels of microRNAs (miRs) and the thickness of epicardial adipose tissue (EAT) in patients with ischemic heart disease (IHD) and borderline coronary artery stenosis (CAS). Material and methods. The study involved 201 patients with stable IHD of functional class (FC) 1–3, having borderline (50–70%) stenoses of the coronary arteries. The first group consisted of 57 (28.4%) patients with increased EAT thickness, while the second group included 144 (71.6%) patients without increased EAT thickness. The levels of the C-terminal fragment of pro-brain natriuretic peptide (NTproBNP) and miR levels (21m2, 133a, 208, 499a) were evaluated. EAT thickness was determined using echocardiography. All patients underwent coronary angiography. Results. The average EAT thickness in the first group was 6.00 [5.00; 6.50] mm, while in the second group it was 3.00 [2.30; 4.00] mm (p < 0.001). Patients in the first group developed arterial hypertension (p < 0.001), IHD (p < 0.001) in general, and myocardial infarction (p = 0.003) at a younger age. There were no significant differences between the groups regarding the prevalence of obesity, type 2 diabetes, angina FC, or the frequency of use of all four main groups of anti-ischemic drugs. A higher level of miR-208 (p = 0.001) and a greater frequency of increased NTproBNP levels (p = 0.002) were found in patients with increased EAT thickness. Conclusion. An elevated level of miR-208, a high frequency of increased NTproBNP, and a younger age at which cardiovascular diseases develop in patients with stable IHD and borderline CAS associated with increased EAT thickness may indicate a poorer prognosis, as they reflect the activity of cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Ostanina et al. (2025) conducted an observational in Ischemic heart disease (IHD) and borderline coronary artery stenosis (CAS) (n=201). Increased epicardial adipose tissue (EAT) thickness vs. Without increased EAT thickness was evaluated on miR-208 levels and frequency of increased NTproBNP (p=0.001). Increased epicardial adipose tissue thickness in patients with stable IHD and borderline coronary stenosis was associated with higher levels of miR-208 (p=0.001) and increased NTproBNP (p=0.002).
Synapse has enriched 10 related papers. Consider them for comparative context: